Blog September 15, 2022
Senior Principal Terry Mahn Authors Medical Device + Diagnostic Industry Article "This Company's False Compliance With CISPR 11 Resulted in a $12 Million FCA Fine"
- Person title
- Senior Principal
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.
Article December 19, 2019
Fish Principal Terry Mahn Authored "The Bad Rap on Pharma: In Defense of Patents," in Pharmaceutical Executive
Blog February 9, 2018
Biosimilars 2017 Year in Review
Article May 19, 2017
Uncertainty In Patent Term Extension For Biologics
Article January 11, 2017
21st Century Cures Act: No Cure for an FDA Patent Bias
Blog December 23, 2016
The First Amendment Does Not Protect All Off-Label Drug Promotion
Blog June 30, 2016
Remedy to Incentivize Innovation as In Vitro Diagnostics Face Patent-Eligibility Challenges and Added Regulatory Scrutiny
Article June 30, 2016
Biologic Patents Are Under Attack
Article December 7, 2015
Will the Trans-Pacific Partnership Derail Biologics?
Article December 2, 2015
Patent Infringement at the ITC: Implications for Brand-Name Drug Companies
Article March 22, 2023
Principals Anita Meiklejohn and Caleb Bates Co-Author Article for One Nucleus Annual Review 2023
Blog March 17, 2023
Legal Alert: The USPTO’s Transition to Electronic Patent Issuance and Reduction in Period Between Issue Notification and Issue Date
Article February 17, 2023
Principals Patrick Darno and Peter Fasse Author "Patent Strategies for Protecting Bioinformatics Inventions" for IAM
Article February 3, 2023
Fish & Richardson Attorneys Author IAM Article "Neglect Begets Opportunity in Femtech IP"
Blog January 17, 2023
Biosimilars 2022 Year in Review
Article December 6, 2022
Start of Unified Patent Court Sunrise Period Postponed to 1 March 2023
Article November 18, 2022
Principal Michael Shepherd Authors Law360 Expert Analysis, "Why PTAB 'Step 2B' Reversal Rates Are Falling"
Article October 20, 2022
Life Sciences Entrepreneur Sourcebook | Intellectual Property: What It Is and Why You Should Care
Article October 12, 2022
Principals Matt Colvin and Betsy Flanagan Author IAM Article "Five Tips to Create a Battle-Ready Portfolio From the Get-Go"
Article September 29, 2022